[go: up one dir, main page]

UA95160U - METHOD OF MEDICAMENTOUS CORRECTION OF FUNCTIONS OF ORGANISM IN PATIENTS WITH ISCHEMIC HEART DISEASE WITH CONSUMER TYPE 2 DIABETES - Google Patents

METHOD OF MEDICAMENTOUS CORRECTION OF FUNCTIONS OF ORGANISM IN PATIENTS WITH ISCHEMIC HEART DISEASE WITH CONSUMER TYPE 2 DIABETES

Info

Publication number
UA95160U
UA95160U UAU201407514U UAU201407514U UA95160U UA 95160 U UA95160 U UA 95160U UA U201407514 U UAU201407514 U UA U201407514U UA U201407514 U UAU201407514 U UA U201407514U UA 95160 U UA95160 U UA 95160U
Authority
UA
Ukraine
Prior art keywords
correction
patients
heart disease
diabetes
functions
Prior art date
Application number
UAU201407514U
Other languages
Russian (ru)
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to UAU201407514U priority Critical patent/UA95160U/en
Publication of UA95160U publication Critical patent/UA95160U/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

Спосіб медикаментозної корекції функцій організму у хворих на ішемічну хворобу серця із супутнім цукровим діабетом 2 типу включає призначення небівололу як засобу корекції діастолічної серцевої недостатності. Додатково поєднано застосовують екстракт родіоли рожевої.The method of drug correction of body functions in patients with coronary heart disease with concomitant type 2 diabetes involves the appointment of nebivolol as a means of correction of diastolic heart failure. Additionally combined use of Rhodiola rosea extract.

UAU201407514U 2014-07-04 2014-07-04 METHOD OF MEDICAMENTOUS CORRECTION OF FUNCTIONS OF ORGANISM IN PATIENTS WITH ISCHEMIC HEART DISEASE WITH CONSUMER TYPE 2 DIABETES UA95160U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201407514U UA95160U (en) 2014-07-04 2014-07-04 METHOD OF MEDICAMENTOUS CORRECTION OF FUNCTIONS OF ORGANISM IN PATIENTS WITH ISCHEMIC HEART DISEASE WITH CONSUMER TYPE 2 DIABETES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201407514U UA95160U (en) 2014-07-04 2014-07-04 METHOD OF MEDICAMENTOUS CORRECTION OF FUNCTIONS OF ORGANISM IN PATIENTS WITH ISCHEMIC HEART DISEASE WITH CONSUMER TYPE 2 DIABETES

Publications (1)

Publication Number Publication Date
UA95160U true UA95160U (en) 2014-12-10

Family

ID=52681349

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201407514U UA95160U (en) 2014-07-04 2014-07-04 METHOD OF MEDICAMENTOUS CORRECTION OF FUNCTIONS OF ORGANISM IN PATIENTS WITH ISCHEMIC HEART DISEASE WITH CONSUMER TYPE 2 DIABETES

Country Status (1)

Country Link
UA (1) UA95160U (en)

Similar Documents

Publication Publication Date Title
CY1124135T1 (en) DOSAGE FORMS FOR THE TREATMENT OF ROMRE'S DISEASE
GT201500011A (en) 5-AMINOTETRAHYDROQUINOLIN-2-NEW CARBOXYLIC ACIDS AND THEIR USE
CR20130649A (en) MODIFIED RELEASE OF 4-METHYL-3 - [[4- (3-PYRIDINYL) -2-PYRIMIDINYL] -AMINO] -N- [5- (4-METHYL-1H-IMIDAZOL-1-IL) -3- (TRIFLUORO -METIL) -PENYL] -BANZAMIDE SOLUBILIZED USING ORGANIC ACIDS
MX356728B (en) Pharmaceutical combination for use in the treatment of diabetes type 2.
CL2015002608A1 (en) Amino-pyrazole compound and related medicinal uses.
AU2014375637A1 (en) Formula of neuregulin preparation
CL2015002835A1 (en) New pyridine derivatives
EP4570314A3 (en) Sacubitril-valsartan dosage regimen for treating chronic systolic heart failure
AU2018326364A1 (en) Methods of enhancing and/or stabilizing cardiac function in patients with Fabry disease
MX2016004325A (en) Novel derivative of an insulin analogue.
MX2017009294A (en) Treatment of pediatric type 2 diabetes mellitus patients with lixisenatide.
BR112017021190A2 (en) pharmaceutical composition and its use
EA201691860A1 (en) PEPTIDE MEDICINE AS A DRY POWDER
EA201792056A1 (en) TREATMENT OF PATIENTS WITH DIABETES MELLITUS TYPE 2
CL2013000021A1 (en) Delta crystalline form of perindopril arginine salt; preparation procedure; pharmaceutical compositions containing it; and its use for the treatment of cardiovascular diseases, such as high blood pressure, heart failure or stable coronary heart disease.
UA95160U (en) METHOD OF MEDICAMENTOUS CORRECTION OF FUNCTIONS OF ORGANISM IN PATIENTS WITH ISCHEMIC HEART DISEASE WITH CONSUMER TYPE 2 DIABETES
TWD192056S (en) Container for medical implant
MY187357A (en) Pharmaceutical composition comprising bisoprolol and perindoril
SG10201809418VA (en) New administration routes of insulin, insulin analogs or derivatives of insulin
TR201902863T4 (en) A PHARMACEUTICAL COMPOSITION CONTAINING ERYTHROPOIETIN AND CEPHTRIACONE AND ITS USE IN THE PRODUCTION OF A DRUG FOR THE TREATMENT OF PARKINSON'S DISEASE.
EA201590473A1 (en) OTAMIKSABAN FOR APPLICATION IN THE TREATMENT OF ACUTE CORONARY SYNDROME WITHOUT STREAMING IN PATIENTS WHO ARE PLANNING FOR AORTOCORONARY BYPASS
UA83410U (en) Method for treatment of patients with chronic pancreatitis with ischemic heart disease at congestive heart failure
UA105536U (en) Method for treatment of diastolic heart dysfunction in patients with type 2 diabetes following non-q-myocardial infarction
UA104202U (en) Method for diagnostics of endothelium dysfunction in patients with stable coronary disease
UA78287U (en) Method for medical rehabilitation of patients with ischemic heart disease in setting of metabolic syndrome